Tom Smith analyst LEERINK

Currently out of the existing stock ratings of Tom Smith, 92 are a BUY (100%).

Tom Smith

Work Performance Price Targets & Ratings Chart

Analyst Tom Smith works at LEERINK with a stock forecast success ratio of 100% fulfilled within 9 days on average.

Tom Smith’s has documented 3 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on KROS, Keros Therapeutics  at 08-Dec-2020.

Wall Street Analyst Tom Smith

Analyst best performing recommendations are on KROS (KEROS THERAPEUTICS ).

Average potential price target upside

KROS Keros Therapeutics 

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

105

$41.81 (66.17%)

110

24 days ago

5/11 (45.45%)

$40.34 (62.39%)

43

Buy

100

$36.81 (58.25%)

100

1 months 7 days ago

0/3 (0%)

$32.34 (47.80%)

Buy

100

$36.81 (58.25%)

100

1 months 19 days ago

1/7 (14.29%)

$31.15 (45.24%)

113

Buy

86

$22.81 (36.10%)

86

5 months 7 days ago

0/4 (0%)

$56.01 (186.76%)

Buy

105

$41.81 (66.17%)

80

1 years 4 months 7 days ago

0/2 (0%)

$53.23 (102.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Tom Smith?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?